Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials

(2018) Michal Juraska et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD4 T cell responses to flaviviruses

(2018) Judith H. Aberle et al.   JOURNAL OF CLINICAL VIROLOGY

Dengue vaccine: WHO position paper, September 2018 – Recommendations

(2018)   VACCINE

Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans

(2017) Alba Grifoni et al.   JOURNAL OF VIROLOGY

Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge

(2017) Jinsheng Wen et al.   Nature Communications

Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults

(2016) Yuka Saito et al.   BMC INFECTIOUS DISEASES

A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys

(2016) Lázaro Gil et al.   JOURNAL OF IMMUNOLOGY

Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs

(2016) Ziyang Sheng et al.   VACCINE

A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates

(2016) Gokul Swaminathan et al.   Scientific Reports

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice

(2016) Chen-Yi Chiang et al.   Scientific Reports

Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus

(2016) Ryohei Saga et al.   Scientific Reports

Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice

(2016) Jieqiong Li et al.   Scientific Reports

Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection

(2015) Ying Wang et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children

(2015) K Chokephaibulkit et al.   Expert Review of Vaccines

An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2

(2015) Chung-Tao Tang et al.   PLoS Neglected Tropical Diseases

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine

(2014) Hui Zhao et al.   PLoS One

Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone

(2014) Zhushi Li et al.   VIRUS RESEARCH

A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman Primates

(2013) X.-F. Li et al.   JOURNAL OF VIROLOGY

Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response

(2013) Fithriyah Sjatha et al.   MICROBIOLOGY AND IMMUNOLOGY

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice

(2013) Jieqiong Li et al.   VACCINE

Suppressive Effects on the Immune Response and Protective Immunity to a JEV DNA Vaccine by Co-administration of a GM-CSF-Expressing Plasmid in Mice

(2012) Hui Chen et al.   PLoS One

Molecular Mechanisms Involved in Antibody-Dependent Enhancement of Dengue Virus Infection in Humans

(2012) Jacky Flipse et al.   TRAFFIC

Flaviviruses and flavivirus vaccines

(2012) Franz X. Heinz et al.   VACCINE

Dengue vaccines: progress and challenges

(2011) Beth-Ann G Coller et al.   CURRENT OPINION IN IMMUNOLOGY

Critical issues in dengue vaccine development

(2011) Stephen J. Thomas et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

(2011) Elisabeth Schuller et al.   VACCINE

The Human Antibody Response to Dengue Virus Infection

(2011) Wahala M. P. B. Wahala et al.   Viruses-Basel

Co-expression of Japanese encephalitis virus prM–E–NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination

(2010) Na Gao et al.   IMMUNOLOGY LETTERS

A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults

(2010) Dennis Morrison et al.   JOURNAL OF INFECTIOUS DISEASES

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

(2010) Yongxin Yu   VACCINE

Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

(2010) Scott J. Balsitis et al.   PLoS Pathogens

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

(2008) M. Lobigs et al.   JOURNAL OF VIROLOGY

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

(2008) C.-Y. Lai et al.   JOURNAL OF VIROLOGY